Cargando…

Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study

BACKGROUND: The aim of this study was to develop nomograms to predict the risk of intrahepatic vascular invasion (IVI) of hepatocellular carcinoma (HCC) patients and estimate the overall survival (OS) and cancer-specific survival (CSS) of HCC patients with IVI. METHODS: The Surveillance, Epidemiolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Shicong, Wang, Zongwen, Zhu, Qiankun, Li, Xiaodong, Ren, Haiyang, Qian, Bo, Hu, Fengli, Xu, Lishan, Zhai, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906056/ https://www.ncbi.nlm.nih.gov/pubmed/36760382 http://dx.doi.org/10.21037/tcr-22-1912

Ejemplares similares

Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma
por: Zhu, Qiankun, et al.
Publicado: (2020)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
por: Lo, Yuan-Chen, et al.
Publicado: (2019)

Is hepatic resection always a better choice than radiofrequency ablation for solitary hepatocellular carcinoma regardless of age and tumor size?
por: Zeng, Shicong, et al.
Publicado: (2023)

The exogenous delivery of microRNA-449b-5p using spermidine-PLGA nanoparticles efficiently decreases hepatic injury
por: Hu, Fengli, et al.
Publicado: (2019)

PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers
por: Yu, Jinling, et al.
Publicado: (2020)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress
por: Zhai, Bo, et al.
Publicado: (2015)

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
por: Menyhárt, Otília, et al.
Publicado: (2018)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma
por: Tang, Zheng, et al.
Publicado: (2019)

Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022)

Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Ding, Linchao, et al.
Publicado: (2022)

Intrahepatic vascular trauma
por: Harfouche, Melike, et al.
Publicado: (2021)

Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
por: Liu, Yun, et al.
Publicado: (2023)

Prognostic values of tissue-resident CD8(+)T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Chen, Lujun, et al.
Publicado: (2023)

Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma
por: Xu, Zhiying, et al.
Publicado: (2020)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Efficacy and prognostic factors of repeated hepatectomy for postoperative intrahepatic recurrence of hepatocellular carcinoma undergoing initial hepatectomy
por: Cen, Feng, et al.
Publicado: (2023)

Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Kis, Bela, et al.
Publicado: (2017)

Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2021)

Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Yi, Xiao, et al.
Publicado: (2023)

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023)

Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study
por: Yuan, Zi-Bo, et al.
Publicado: (2022)

A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion
por: Chen, Wei, et al.
Publicado: (2022)

Identification of Prognostic Genes in Hepatocellular Carcinoma
por: Bai, Wenhui, et al.
Publicado: (2022)

Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
por: Dong, Jiejie, et al.
Publicado: (2017)

Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
por: Chen, Lang, et al.
Publicado: (2020)

Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition
por: ZHOU, CHUANG, et al.
Publicado: (2015)

Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma
por: Yu, Yuan-Quan, et al.
Publicado: (2016)

Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma
por: Yi, Bo, et al.
Publicado: (2020)

Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection
por: Li, Hui, et al.
Publicado: (2020)

Prognostic Impact of Tumor Budding in Intrahepatic Cholangiocellular Carcinoma
por: Budau, Klara-Luisa, et al.
Publicado: (2022)

Prognostic impact of tumor size on isolated hepatocellular carcinoma without vascular invasion may have age variance
por: Zhang, Yi, et al.
Publicado: (2023)

CD24–p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages
por: Li, Dongling, et al.
Publicado: (2018)

The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma
por: Kim, Jong Man, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_12knihmeduajsibsai5igj4pt9